Skip to main content
. Author manuscript; available in PMC: 2015 Jul 13.
Published in final edited form as: Immunol Lett. 2008 Oct 7;121(2):87–92. doi: 10.1016/j.imlet.2008.09.001

Fig. 2. Pulmonary CD4+CD25+ cells of OVA-sensitized and challenged C57BL/6 mice treated with antibodies against TCR-γδ.

Fig. 2

A. Mice were treated as described in Fig.1. Pulmonary cells recovered 48 h after the last OVA challenge were stimulated with PMA/ionomycin in the presence of brefeldin A, and then stained with antibodies specific for CD4, CD25 and intracellular IL-10, as described in Materials and Methods. For three-color fluorescent analysis, cells were gated based on their scatter profile (lymphocyte gate) and on CD4-expression. 2.5 × 104 gated cells were counted in each histogram.

B. Cell frequencies were determined cytofluorimetrically as described in 2A. Absolute cell numbers were obtained by multiplying the cell frequencies (percentage of CD4+CD25+ or CD4+CD25+ IL-10+ cells) by the number of cells obtained in lung digests. Results for each group are expressed as mean ± SEM (n = 12 in each group).